tetano
Editor, Senior Moderator
Open Forum Infect Dis
. 2021 Jan 4;8(2)
faa658.
doi: 10.1093/ofid/ofaa658. eCollection 2021 Feb.
COVID-19 Vaccine Acceptance: We Need to Start Now
Krutika Kuppalli[SUP] 1 [/SUP], David M Brett-Major[SUP] 2 [/SUP], Tara C Smith[SUP] 3 [/SUP]
Affiliations
Abstract
In this perspective, we discuss the importance of developing a vaccine to help curb transmission of severe acute respiratory syndrome coronavirus 2. The question remains: Once a safe and effective vaccine is developed, will the public be willing to get it? We present information from one of the first tracking polls to assess public attitudes and perceptions toward a possible coronavirus disease 2019 vaccine that suggests public hesitancy over a potential vaccine, concern regarding accelerating clinical trials, and unease over the vaccine approval process. Public health experts, government officials, advocates, and others in the scientific community should respect the signals of hesitancy and communicate sensitivity, applying lessons not only to how we message, but also in how we build this urgently needed vaccine if we are to have successful uptake once available.
Keywords: COVID-19; SARS-CoV-2; public health; vaccine.
. 2021 Jan 4;8(2)
faa658.doi: 10.1093/ofid/ofaa658. eCollection 2021 Feb.
COVID-19 Vaccine Acceptance: We Need to Start Now
Krutika Kuppalli[SUP] 1 [/SUP], David M Brett-Major[SUP] 2 [/SUP], Tara C Smith[SUP] 3 [/SUP]
Affiliations
- PMID: 33623802
- PMCID: PMC7798542
- DOI: 10.1093/ofid/ofaa658
Abstract
In this perspective, we discuss the importance of developing a vaccine to help curb transmission of severe acute respiratory syndrome coronavirus 2. The question remains: Once a safe and effective vaccine is developed, will the public be willing to get it? We present information from one of the first tracking polls to assess public attitudes and perceptions toward a possible coronavirus disease 2019 vaccine that suggests public hesitancy over a potential vaccine, concern regarding accelerating clinical trials, and unease over the vaccine approval process. Public health experts, government officials, advocates, and others in the scientific community should respect the signals of hesitancy and communicate sensitivity, applying lessons not only to how we message, but also in how we build this urgently needed vaccine if we are to have successful uptake once available.
Keywords: COVID-19; SARS-CoV-2; public health; vaccine.